Progression and metastasis of lung cancer
HH Popper - Cancer and Metastasis Reviews, 2016 - Springer
… Metastasis in lung cancer is a multifaceted process. In this review, we will dissect the process
in several isolated steps such as angiogenesis, hypoxia, circulation, and establishment of …
in several isolated steps such as angiogenesis, hypoxia, circulation, and establishment of …
Cancer progress and priorities: lung cancer
MB Schabath, ML Cote - Cancer epidemiology, biomarkers & prevention, 2019 - AACR
… lung cancer patient outcomes leading to curable lung cancer among early-stage diagnoses
and a chronic and manageable disease for patients with advanced and metastatic disease. …
and a chronic and manageable disease for patients with advanced and metastatic disease. …
Small-cell lung cancer
CM Rudin, E Brambilla, C Faivre-Finn… - Nature Reviews Disease …, 2021 - nature.com
… Although clinical progress in SCLC treatment has been notoriously slow, a better understanding
of the biology of disease has uncovered novel vulnerabilities that might be amenable to …
of the biology of disease has uncovered novel vulnerabilities that might be amenable to …
[PDF][PDF] Prognosis of different types of non-small cell lung cancer progression: current state and perspectives
AA Schegoleva, AA Khozyainova… - Cell Physiol …, 2021 - cellphysiolbiochem.com
… Surgical pathology has an important role in the diagnosis and treatment of lung cancer [24].
Despite the remarkable progress in molecular pathology related mainly to the development …
Despite the remarkable progress in molecular pathology related mainly to the development …
Molecular mechanisms of pulmonary fibrogenesis and its progression to lung cancer: a review
T Kinoshita, T Goto - International journal of molecular sciences, 2019 - mdpi.com
… In conclusion, cancer and fibrosis are both severe lung diseases, and they share biological
pathways. Although the specific genetic and cellular mechanisms are not yet fully understood…
pathways. Although the specific genetic and cellular mechanisms are not yet fully understood…
[HTML][HTML] Circulating biomarkers for monitoring therapy response and detection of disease progression in lung cancer patients
R de Kock, B van den Borne, M Youssef-El Soud… - Cancer Treatment and …, 2021 - Elsevier
Liquid biopsies have become of interest as minimally invasive ways to monitor treatment
response in lung cancer patients. Circulating tumor DNA (ctDNA) and protein biomarkers are …
response in lung cancer patients. Circulating tumor DNA (ctDNA) and protein biomarkers are …
[HTML][HTML] Scientific advances in lung cancer 2015
AS Tsao, GV Scagliotti, PA Bunn Jr, DP Carbone… - Journal of Thoracic …, 2016 - Elsevier
… However, significant progress is underway in both the prevention and treatment of lung
cancer. Lung cancer therapy has now emerged as a “role model” for precision …
cancer. Lung cancer therapy has now emerged as a “role model” for precision …
Lower airway dysbiosis affects lung cancer progression
JCJ Tsay, BG Wu, I Sulaiman, K Gershner, R Schluger… - Cancer discovery, 2021 - AACR
… effects of lower airway dysbiosis on lung cancer progression, we tested the effects of lower
airway dysbiosis induced by Veillonella parvula in a preclinical lung cancer model (KP mice; …
airway dysbiosis induced by Veillonella parvula in a preclinical lung cancer model (KP mice; …
The biology and management of non-small cell lung cancer
RS Herbst, D Morgensztern, C Boshoff - Nature, 2018 - nature.com
… In this Review, we provide an overview of the recent progress made in lung cancer biology
and treatment, including the most promising strategies that have already made a notable …
and treatment, including the most promising strategies that have already made a notable …
Healthcare costs in patients with advanced non-small cell lung cancer and disease progression during targeted therapy: a real-world observational study
KE Skinner, AW Fernandes, MS Walker… - Journal of medical …, 2018 - Taylor & Francis
… in patients with advanced non-small cell lung cancer (NSCLC… disease progression. Monthly
Medicare-paid costs were evaluated during the TKI therapy period and following progression…
Medicare-paid costs were evaluated during the TKI therapy period and following progression…
相关搜索
- disease progression in lung cancer patients
- cell lung cancer
- epidemiology of lung cancer
- non-small cell lung cancer tumor dna
- epidemiology etiology and prevention lung cancer
- idiopathic pulmonary fibrosis lung cancer
- cost effectiveness lung cancer
- lung cancer progression lower airway dysbiosis
- airway microbiota lung cancer
- global burden of lung cancer
- tumor dna in lung cancer
- therapeutic targets in lung cancer
- immunotherapy efficacy in lung cancer
- lung cancer invasion and metastasis
- non-small cell lung cancer liquid biopsy
- non-small cell lung cancer targeted therapies